购物车
- 全部删除
- 您的购物车当前为空
Claudin-18 Protein, Human, Recombinant (CLDN18.1) is expressed in HEK293 mammalian cells. The predicted molecular weight is 27.86 kDa and the accession number is P56856-1.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
20 μg | ¥ 5,330 | 5日内发货 | |
100 μg | ¥ 10,600 | 5日内发货 | |
500 μg | ¥ 33,800 | 5日内发货 |
生物活性 | Immobilized Human Claudin18.1-VLP (Full Length) Protein at 5 μg/mL (100 μL/well) can bind Anti-Human claudin18.1 Antibody, Rabbit IgG1, the EC50 is 0.8 ng/mL (QC tested). |
产品描述 | Claudin-18 Protein, Human, Recombinant (CLDN18.1) is expressed in HEK293 mammalian cells. The predicted molecular weight is 27.86 kDa and the accession number is P56856-1. |
种属 | Human |
表达系统 | HEK293 Cells |
标签 | Tag Free |
蛋白编号 | P56856-1 |
别名 | SFTPJ,SFTA5,claudin 18 |
蛋白构建 | A DNA sequence encoding the human CLDN18 (P56856-1) (Met1-Val261) was expressed. Predicted N terminal: Met 1 |
分子量 | 27.86 kDa (predicted) |
内毒素 | < 1.0 EU/μg of the protein as determined by the LAL method. |
缓冲液 | Supplied as sterile 50 mM Hepes, 150 mM NaCl 10% Trehalose, pH 7.2. |
存储 | It is recommended to store the product under sterile conditions at -70°C or lower. Samples are stable for up to 12 months at -80°C. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
运输方式 | In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice. |
研究背景 | Claudins family member Claudin18 (CLDN18) is a four-pass transmembrane protein with two extracellular loops and cytoplasmic N- and C-tails found in tight junctions. CLDN18 modulates paracellular permeability, polarity, and signaling. CLDN18 deficiency has been associated with atrophic gastritis, spasmolytic polypeptide-expressing metaplasia (SPEM), and asthma. Lung-specific CLDN18.1 modulates alveolar epithelial type II (AT2) cell proliferation and organ size. Restoration of CLDN18.1 expression in human lung cancer cells has been shown to suppress proliferation, inhibiting the IGF-1R/AKT axes. Not expressed in other healthy tissues, gastric mucosa-specific isoform CLDN18.2 expression manifests in primary gastric cancers. CLDN18.2 at the surface of epithelial tumor cells is a target in antibody and CAR-therapies currently in development. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.